EE05186B1 - 4-halogeenitud-17-metleensteroidid, nende valmistamismeetod ja neid hendeid sisaldavad farmatseutilised kompositsioonid - Google Patents

4-halogeenitud-17-metleensteroidid, nende valmistamismeetod ja neid hendeid sisaldavad farmatseutilised kompositsioonid

Info

Publication number
EE05186B1
EE05186B1 EEP200300087A EEP200300087A EE05186B1 EE 05186 B1 EE05186 B1 EE 05186B1 EE P200300087 A EEP200300087 A EE P200300087A EE P200300087 A EEP200300087 A EE P200300087A EE 05186 B1 EE05186 B1 EE 05186B1
Authority
EE
Estonia
Prior art keywords
pharmaceutical compositions
compositions containing
compounds
halogenated
preparation
Prior art date
Application number
EEP200300087A
Other languages
English (en)
Estonian (et)
Inventor
Menzenbach Bernd
Elger Walter
Droescher Peter
Hillisch Alexander
Kaufmann G�nter
Schweikert Hans-Udo
Mller Gerd
Original Assignee
Jenapharm Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh & Co. Kg filed Critical Jenapharm Gmbh & Co. Kg
Publication of EE200300087A publication Critical patent/EE200300087A/xx
Publication of EE05186B1 publication Critical patent/EE05186B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200300087A 2000-09-04 2001-08-29 4-halogeenitud-17-metleensteroidid, nende valmistamismeetod ja neid hendeid sisaldavad farmatseutilised kompositsioonid EE05186B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10043846A DE10043846A1 (de) 2000-09-04 2000-09-04 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen
PCT/EP2001/009943 WO2002019971A1 (de) 2000-09-04 2001-08-29 4-halogenierte 17-methylensteroide, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen

Publications (2)

Publication Number Publication Date
EE200300087A EE200300087A (et) 2005-02-15
EE05186B1 true EE05186B1 (et) 2009-06-15

Family

ID=7655148

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300087A EE05186B1 (et) 2000-09-04 2001-08-29 4-halogeenitud-17-metleensteroidid, nende valmistamismeetod ja neid hendeid sisaldavad farmatseutilised kompositsioonid

Country Status (29)

Country Link
EP (1) EP1423407B1 (zh)
JP (1) JP2004513084A (zh)
KR (1) KR100530816B1 (zh)
CN (1) CN1262560C (zh)
AT (1) ATE319733T1 (zh)
AU (2) AU2002210470B2 (zh)
BG (1) BG107594A (zh)
BR (1) BR0113618A (zh)
CA (1) CA2421302C (zh)
DE (2) DE10043846A1 (zh)
DK (1) DK1423407T3 (zh)
EA (1) EA006387B1 (zh)
EE (1) EE05186B1 (zh)
ES (1) ES2260294T3 (zh)
HK (1) HK1060135A1 (zh)
HR (1) HRP20030256A2 (zh)
HU (1) HUP0300936A3 (zh)
IL (2) IL154666A0 (zh)
ME (1) MEP14408A (zh)
MX (1) MXPA03001912A (zh)
NO (1) NO325012B1 (zh)
NZ (1) NZ524485A (zh)
PL (1) PL360669A1 (zh)
PT (1) PT1423407E (zh)
RS (1) RS50305B (zh)
SK (1) SK286757B6 (zh)
UA (1) UA74592C2 (zh)
WO (1) WO2002019971A1 (zh)
ZA (1) ZA200301715B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141984A1 (de) * 2001-08-28 2003-03-20 Jenapharm Gmbh Neue 17-Methylen-4-azasteroide
US7199115B2 (en) 2004-04-19 2007-04-03 Schering Ag 17α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making them
AT12800U1 (de) * 2007-11-05 2012-11-15 Bayer Schering Pharma Ag Pharmazeutisches Präparat zur Verwendung bei der oralen Kontrazeption von Frauen mit Laktoseintoleranz

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2611773A (en) * 1951-08-21 1952-09-23 Upjohn Co Estradiol 17-cyclopenetanepropionate
US3146239A (en) * 1957-09-23 1964-08-25 Syntex Corp 4-halo-19-nor-progesterone
US3232960A (en) * 1959-10-08 1966-02-01 Upjohn Co 3-keto-4-fluoro- and 3-keto-4,4-difluorosteroids and process
US3661940A (en) * 1970-04-13 1972-05-09 Sandoz Ag Derivatives of 21-methyl-19-norpregnanes
US4389345A (en) * 1981-10-09 1983-06-21 G.D. Searle & Co. 3-Oxoestra-17-acetonitrile and unsaturated analogs
US5994334A (en) * 1997-02-05 1999-11-30 University Of Maryland Androgen synthesis inhibitors
WO2002000681A1 (en) * 2000-06-27 2002-01-03 Aventis Pharma S.A. 20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase

Also Published As

Publication number Publication date
WO2002019971A1 (de) 2002-03-14
SK2442003A3 (en) 2003-08-05
DE50109175D1 (de) 2006-05-04
SK286757B6 (sk) 2009-05-07
ZA200301715B (en) 2004-08-13
CN1452628A (zh) 2003-10-29
NO325012B1 (no) 2008-01-14
PL360669A1 (en) 2004-09-20
WO2002019971A9 (de) 2002-08-08
HUP0300936A2 (hu) 2003-11-28
MEP14408A (en) 2010-06-10
HUP0300936A3 (en) 2010-01-28
BR0113618A (pt) 2003-07-15
RS50305B (sr) 2009-09-08
MXPA03001912A (es) 2004-07-08
EA200300322A1 (ru) 2003-10-30
CA2421302A1 (en) 2003-03-03
PT1423407E (pt) 2006-07-31
DK1423407T3 (da) 2006-07-03
UA74592C2 (en) 2006-01-16
IL154666A (en) 2008-12-29
KR100530816B1 (ko) 2005-11-25
DE10043846A1 (de) 2002-04-04
YU16403A (sh) 2006-05-25
EA006387B1 (ru) 2005-12-29
EE200300087A (et) 2005-02-15
HRP20030256A2 (en) 2005-10-31
CA2421302C (en) 2007-08-14
NO20030989L (no) 2003-05-02
EP1423407A1 (de) 2004-06-02
BG107594A (bg) 2003-09-30
AU2002210470B2 (en) 2006-07-20
IL154666A0 (en) 2003-09-17
KR20030028836A (ko) 2003-04-10
AU1047002A (en) 2002-03-22
NZ524485A (en) 2005-11-25
NO20030989D0 (no) 2003-03-03
ATE319733T1 (de) 2006-03-15
EP1423407B1 (de) 2006-03-08
JP2004513084A (ja) 2004-04-30
ES2260294T3 (es) 2006-11-01
HK1060135A1 (en) 2004-07-30
CN1262560C (zh) 2006-07-05

Similar Documents

Publication Publication Date Title
BE2015C026I2 (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
MA26843A1 (fr) NOUVELLES COMPOSITIONS ESTRO-PROGESTATIVES TOPIQUES à EFFET SYSTÉMIQUE
HUP0102483A2 (hu) Androszt-5-én-3béta, 17béta-diolt tartalmazó gyógyszerkészítmények
RS49756B (sr) Primena ksenona ili smeša ksenonskog gasa za proizvodnju farmaceutskog preparata za lečenje neurointoksikacija
ATE411336T1 (de) Verfahren zur behandlung von birkenrinde und die isolierung von natürlichen produkten davon
ATE452641T1 (de) Orale pharmazeutische zusammensetzung enthaltend 15-hydroxytestosteron und seine derivate
ATE293979T1 (de) Pharmazeutische zusammensetzungen enthaltend syntethisch natürliche progesteron und estradiol und verfahren zur herstellung derselben
DE60115274D1 (de) Verwendung von antiprogestinen zur prophylaxe und behandlung von hormonabhängigen erkrankungen
JP2004508317A5 (zh)
BR0008437A (pt) Inibidores esteróides de sulfatase e métodos parafabricação e uso dos mesmos
EE05186B1 (et) 4-halogeenitud-17-metleensteroidid, nende valmistamismeetod ja neid hendeid sisaldavad farmatseutilised kompositsioonid
BR9707844A (pt) Combinação de desidroepiandrosterona e inibidores de aromatase e emprego desta combinação para a preparação de um medicamento para o tratamento de uma deficiência de androgênio relativa e absoluta no homem
EA200100674A1 (ru) Клатраты дегидроэпиандростерона и соответствующие фармацевтические композиции
RS20050816A (en) Pure d-(17alpha)-13-ethyl-17-hydroxy- 18,19-dinopregn-4-ene- 20-yne-3-one-3e- and-3z-oxime isomers,as well as process for the synthesis of the mixture of isomers and the pure isomers
ATE252849T1 (de) Mittel zur stabilisierung von lebensmitteln und kosmetischen mitteln sowie verfahren zu dessen herstellung
NO20022713D0 (no) 14,15-syklopropansteroider fra 19-norandrostanserien, fremgangsmåte for fremstilling av forbindelsene, og farmasöytiskepreparater som inneholder forbindelsene
BR0016092A (pt) Composto, uso de um composto kit para contracepção hormonal em um macho, e, método de tratamento

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20100829